Work

P2.04-002 CASPIAN: Phase 3 Study of First-Line Durvalumab ± Tremelimumab + Platinum-Based Chemotherapy vs Chemotherapy Alone in ED-SCLC

Year: 2017

Type: article

Source: Journal of Thoracic Oncology

DOI: 10.1016/j.jtho.2017.11.015

Authors: L. Paz-Ares, H. Jiang, Y. Huang, P. Dennis

Institutions: Hospital Universitario 12 De Octubre, AstraZeneca (United States)

Language: English

Topic: Lung Cancer Research Studies

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W2770548457

FWCI: 0.364

Cites:

Cited by: 7

Related to: 10